Auemduan Prawan
Khon Kaen, 40002, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Identification of Prognostic Factors in Esophageal Cancer Using Machine Learning: A Retrospective Study Based on the SEER Database.
Journal: Journal of clinical medicine
Published: March 11, 2026
Brusatol enhances the chemotherapy efficacy of Cisplatin and Gemcitabine in KKU-100 cholangiocarcinoma cells through ROS-mediated apoptosis.
Journal: Scientific reports
Published: December 08, 2025
Unveiling the Anticancer Potential and Molecular Mechanisms of Fangchinoline Against Cholangiocarcinoma Using FTIR Microspectroscopy, In Vitro and In Silico Approaches.
Journal: Integrative cancer therapies
Published: November 20, 2025
Repurposing Rosiglitazone Induces Apoptosis Accompanied by Impaired Antioxidant Defense in Cholangiocarcinoma Cells: Findings from Proteomic and Functional Analyses.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 15, 2025
Expression and Prognostic Implication of the Nuclear Receptors Farnesoid X Receptor and Pregnane X Receptor in Human Cholangiocarcinoma.
Journal: Cancer diagnosis & prognosis
Published: March 14, 2025
Synergistic suppression of cholangiocarcinoma cells via DNA damage response and cell cycle arrest by dual targeting PARP and ATM in DNA damage repair pathway.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 25, 2025
Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization.
Journal: Scientific reports
Published: August 05, 2024
Dual blockage of PI3K-mTOR and FGFR induced autophagic cell death in cholangiocarcinoma cells.
Journal: Heliyon
Published: September 25, 2023
Network pharmacology- and cell-based assessments identify the FAK/Src pathway as a molecular target for the antimetastatic effect of momordin Ic against cholangiocarcinoma.
Journal: Heliyon
Published: September 08, 2023
FGF10/FGFR2 Signaling: Therapeutically Targetable Vulnerability in Ligand-responsive Cholangiocarcinoma Cells.
Journal: In vivo (Athens, Greece)
Published: April 21, 2023
Anti-metastatic Potential of Natural Triterpenoid Cucurbitacin B Against Cholangiocarcinoma Cells by Targeting Src Protein.
Journal: Integrative cancer therapies
Published: September 26, 2022
A rare isoflavone-quinone and a new flavanone from the roots of Dalbergia stipulacea Roxb.
Journal: Natural product research
Published: March 18, 2022
Last Updated: 09/26/2026